Charles Bramlage

Mr. Charles J.
Bramlage is a Chief Executive Officer at Yamo Pharmaceuticals LLC.
He is on the Board of Directors at Clarametyx Biosciences, Inc. Mr. Bramlage was previously employed as an Independent Director by Eiger BioPharmaceuticals, Inc., an Independent Director by BioDelivery Sciences International, Inc., a President, Chief Executive Officer & Director by Pearl Therapeutics, Inc., a President-Pharmaceutical Products by Covidien Ltd., a President-North America & EMEA by Valeant Pharmaceuticals International Corp., a President & Chief Executive Officer by BattellePharma Inc., a VP-Respiratory Global Commercial Development by GlaxoSmithKline Plc, and a Principal by Merck & Co., Inc. He also served on the board at Locus Biosciences, Inc. He received his undergraduate degree from Fisher College of Business and an MBA from the University of Dayton.